Golden State Wealth Management LLC Makes New $867,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Golden State Wealth Management LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 1,714 shares of the healthcare conglomerate’s stock, valued at approximately $867,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Archer Investment Corp raised its stake in UnitedHealth Group by 10.3% in the 4th quarter. Archer Investment Corp now owns 2,777 shares of the healthcare conglomerate’s stock worth $1,405,000 after purchasing an additional 259 shares in the last quarter. Beese Fulmer Investment Management Inc. boosted its stake in shares of UnitedHealth Group by 2.2% in the fourth quarter. Beese Fulmer Investment Management Inc. now owns 23,271 shares of the healthcare conglomerate’s stock valued at $11,772,000 after buying an additional 511 shares during the period. Fairvoy Private Wealth LLC bought a new position in UnitedHealth Group during the 4th quarter worth $420,000. Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of UnitedHealth Group by 441.9% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 40,162 shares of the healthcare conglomerate’s stock worth $20,316,000 after purchasing an additional 32,750 shares in the last quarter. Finally, BSN CAPITAL PARTNERS Ltd increased its holdings in UnitedHealth Group by 50.1% in the 4th quarter. BSN CAPITAL PARTNERS Ltd now owns 72,818 shares of the healthcare conglomerate’s stock valued at $36,418,000 after buying an additional 24,298 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $529.71 on Friday. The firm has a market capitalization of $487.48 billion, a price-to-earnings ratio of 34.17, a PEG ratio of 1.48 and a beta of 0.61. The stock’s 50 day moving average is $532.43 and its 200-day moving average is $564.77. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.83 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Bank of America lowered their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens upped their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.